Carmustine 100mg Injection
Carmustine 100mg injection is used for the treatment of the following:
The medication comes under the international brand name of bicnu and an Indian brand name of consium.
Bicnu injection is used as palliative therapy in a single dose to treat patients. The active ingredient in carmustine 100mg injection is nitrosourea which works on the tumor cells and stops the proliferation of it. The drug is packaged as a lyophilized pale yellow color solution.
The carmustine 100mg injection interaction with cimetidine results in greater myelosuppression and with phenobarbital, it results in induced metabolism of carmustine. With this, another type of drug interaction is also seen which causes problems in the user body.
1. What is Consium 100 mg Injection?
Consium 100 mg Injection contains carmustine, an anticancer medicine belonging to the nitrosourea group. Lotus International lists Consium as the Indian brand corresponding to the international brand BiCNU.
2. What is Consium (Carmustine) used for?
Consium is used in the treatment of certain brain tumors, including glioblastoma, brainstem glioma, astrocytoma, ependymoma, and metastatic brain tumors. It may also be used with other medicines for certain Hodgkin’s and non-Hodgkin’s lymphomas.
3. How is Consium 100 mg Injection administered?
Consium is administered intravenously by a qualified healthcare professional. The route, dosage, and treatment schedule should be determined by the treating oncologist according to the patient’s condition.
4. What is the recommended dosage of Consium?
The dosage of carmustine varies according to the patient’s condition and treatment protocol. Lotus International provides dosing information based on body surface area. Consium should only be administered according to a physician’s prescription.
5. What are the possible side effects of Consium?
Possible side effects may include nausea, vomiting, diarrhea, loss of appetite, changes in blood counts, liver-related changes, kidney problems, and allergic reactions. Patients should be medically monitored during treatment.